Suppr超能文献

眼科临床应用的注射用皮质类固醇的粒径及药物相互作用

Particle size and drug interactions of injectable corticosteroids used in ophthalmic practice.

作者信息

Francis B A, Chang E L, Haik B G

机构信息

Tulane University, Department of Ophthalmology, New Orleans.

出版信息

Ophthalmology. 1996 Nov;103(11):1884-8. doi: 10.1016/s0161-6420(96)30411-9.

Abstract

PURPOSE

The aim of this study is to compare the particle sizes of commercially available corticosteroids for intralesional injection to manufacturers' specifications and to evaluate changes in size when mixed with other steroids and other commonly used solutions.

METHODS

The particle sizes of dexamethasone sodium phosphate, methylprednisolone acetate, triamcinolone acetonide, and betamethasone sodium phosphate and beta-methasone acetate were measured with the Coulter counter. Each steroid was mixed with each of the others, lidocaine, and lidocaine with epinephrine, then measured immediately and after 1 hour to determine the effect on particle size.

RESULTS

All steroids showed accurate manufacturer specifications. Dexamethasone showed an increase in particle size when mixed with lidocaine alone, immediately and after 1 hour. Triamcinolone showed an increase in particle size only after 1 hour after mixture with lidocaine alone. Triamcinolone, dexamethasone, and methylprednisolone particles increased in size when mixed with lidocaine and epinephrine. Dexamethasone and triamcinolone showed an additional increase in size when allowed to sit for 1 hour after mixture with lidocaine and epinephrine. Mixing steroids caused no increase in particle size.

CONCLUSION

Because an increase in the number of particles greater than 20 microns in a solution also increases the likelihood of vascular occlusion, the authors urge care in the mixing of these drugs, especially with lidocaine and epinephrine. If mixture is necessary, the authors recommend that injection take place immediately subsequent.

摘要

目的

本研究旨在比较市售用于病灶内注射的皮质类固醇的粒径与制造商的规格,并评估与其他类固醇及其他常用溶液混合时粒径的变化。

方法

使用库尔特计数器测量磷酸地塞米松钠、醋酸甲泼尼龙、曲安奈德以及磷酸倍他米松和醋酸倍他米松的粒径。将每种类固醇分别与其他类固醇、利多卡因以及含肾上腺素的利多卡因混合,然后立即及1小时后进行测量,以确定对粒径的影响。

结果

所有类固醇的粒径均符合制造商的准确规格。单独与利多卡因混合时,地塞米松在立即及1小时后粒径均增大。单独与利多卡因混合后,曲安奈德仅在1小时后粒径增大。与利多卡因和肾上腺素混合时,曲安奈德、地塞米松和甲泼尼龙的粒径增大。与利多卡因和肾上腺素混合后静置1小时,地塞米松和曲安奈德的粒径进一步增大。混合类固醇不会导致粒径增大。

结论

由于溶液中大于20微米的颗粒数量增加也会增加血管阻塞的可能性,作者敦促在混合这些药物时要谨慎,尤其是与利多卡因和肾上腺素混合时。如果有必要混合,作者建议随后立即进行注射。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验